Home › Funds › Thrivent › Thrivent Small Cap Growth Fund
Fund family: Thrivent · Filed by THRIVENT MUTUAL FUNDS (CIK 811869) · SEC series S000061362
Ticker: TSCGX (C000198646)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 685 with, 4 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 2 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Thrivent’s manager page (222,957 ballot items across 50 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Thrivent | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 93.7% | 671 | 93.8% | 192,489 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 1.2% | 2,125 |
Each ballot item this fund voted is set against the votes of the other Thrivent funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Thrivent funds on all 688 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 97.8% of this fund’s 689 such votes could be given a sector; the other 15 (2.2%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 149 | 0 | 0.0% |
| Health Care | 142 | 2 | 1.4% |
| Industrials | 132 | 2 | 1.5% |
| Technology | 93 | 0 | 0.0% |
| Finance | 85 | 0 | 0.0% |
| Energy | 26 | 0 | 0.0% |
| Miscellaneous | 22 | 0 | 0.0% |
| Utilities | 10 | 0 | 0.0% |
| Basic Materials | 5 | 0 | 0.0% |
| Consumer Staples | 5 | 0 | 0.0% |
| Real Estate | 5 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 478 | 0 |
| Say-on-Pay | 91 | 2 |
| Audit-related | 80 | 0 |
| Compensation | 19 | 0 |
| Corporate Governance | 17 | 2 |
| Extraordinary Transactions | 8 | 0 |
| Capital Structure | 4 | 0 |
| Shareholder Rights and Defenses | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| RBC Bearings Incorporated | September 4, 2025 | $5M | 6 | 0 |
| Agilysys, Inc. | September 4, 2025 | $5M | 10 | 0 |
| Modine Manufacturing Company | August 21, 2025 | $4M | 6 | 0 |
| Twist Bioscience Corporation | February 5, 2026 | $3M | 5 | 0 |
| Houlihan Lokey, Inc. | September 17, 2025 | $2M | 5 | 0 |
| CorVel Corporation | August 7, 2025 | $2M | 8 | 0 |
| Boot Barn Holdings, Inc. | August 27, 2025 | $2M | 11 | 0 |
| Champion Homes, Inc. | July 24, 2025 | $2M | 10 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | Against | For |
| May 15, 2026 | Medpace Holdings, Inc. | Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposal | Against | For |
| May 21, 2026 | Constellium SE | Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every two years | Against | For |
| May 21, 2026 | Constellium SE | Advisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every three years | Against | For |
These funds reported the same votes as Thrivent Small Cap Growth Fund in the latest season, so they share this page:
698 ballot items at 87 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Thrivent Small Cap Growth Fund (TSCGX) voted at 87 shareholder meetings of 83 companies, on 698 ballot items in all. Where management made a recommendation, the fund followed it on 99.4% of the items and voted against it 4 times. Its most frequent area of disagreement was say-on-pay (2 of its votes against management). It voted on 2 shareholder proposals. It voted FOR the board's own proposals about as often as Thrivent's funds as a whole (93.7% against 93.8%). It voted the same way as most Thrivent funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Thrivent’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.